NVST 内幕交易
NVST 的 SEC Form 4 内幕交易记录
总交易
59
买入
0
买入总额
-
卖出总额
$801K
| 信号 | 内幕人 | 职位 | 方向 | 股数 | 价格 | 金额 | 日期 | 信号原因 |
|---|---|---|---|---|---|---|---|---|
| ★★★★★(16) | REIS MISCHA | SVP, Strategy & Bus. Dev. | 卖出 | 8,000 | $27.50 | $220K | 2026-08-20 | 高管卖出, 减持超20%持仓 |
| ★★★★★(8) | REIS MISCHA | SVP, Strategy & Bus. Dev. | 卖出 | 5,634 | $30.00 | $169K | 2026-02-10 | 高管卖出 |
| ★★★★★(8) | REIS MISCHA | SVP, Strategy & Bus. Dev. | 卖出 | 4,041 | $30.00 | $121K | 2026-02-10 | 高管卖出 |
| ★★★★★(8) | REIS MISCHA | SVP, Strategy & Bus. Dev. | 卖出 | 9,675 | $30.00 | $290K | 2026-02-10 | 高管卖出 |
| ★★★★★(0) | NILSSON STEFAN | President, Nobel Biocare | 卖出 | 804 | $27.47 | $22K | 2026-08-25 | |
| ★★★★★(0) | ACURIO VERONICA | President, Orthodontics | 卖出 | 7,710 | $27.47 | $212K | 2026-08-25 | |
| ★★★★★(0) | HAMMES ERIC D. | Chief Financial Officer | 卖出 | 10,885 | $27.47 | $299K | 2026-08-25 | |
| ★★★★★(0) | BEFIDI ROBERT | President, Diagnostics | 卖出 | 5,147 | $27.47 | $141K | 2026-08-25 | |
| ★★★★★(0) | KEEL PAUL A | Chief Executive Officer | 卖出 | 179,730 | - | - | 2026-08-18 | |
| ★★★★★(0) | KEEL PAUL A | Chief Executive Officer | 卖出 | 159,900 | - | - | 2026-08-18 | |
| ★★★★★(0) | HAMMES ERIC D. | Chief Financial Officer | 卖出 | 47,970 | - | - | 2026-08-18 | |
| ★★★★★(0) | THOMAS COREE K. | CAO | 卖出 | 0 | - | - | 2026-08-06 | |
| ★★★★★(0) | KEEL PAUL A | Chief Executive Officer | 卖出 | 12,811 | $23.43 | $300K | 2026-05-25 | |
| ★★★★★(0) | HUENNEKENS R SCOTT | - | 卖出 | 12,585 | - | - | 2026-05-19 | |
| ★★★★★(0) | GALLAHUE KIERAN | - | 卖出 | 9,330 | - | - | 2026-05-19 | |
| ★★★★★(0) | TSINGOS CHRISTINE A | - | 卖出 | 9,330 | - | - | 2026-05-19 | |
| ★★★★★(0) | RASKAS DANIEL | - | 卖出 | 9,330 | - | - | 2026-05-19 | |
| ★★★★★(0) | CARRUTHERS WENDY | - | 卖出 | 9,330 | - | - | 2026-05-19 | |
| ★★★★★(0) | PIERCE JAMES ANDREW | - | 卖出 | 9,330 | - | - | 2026-05-19 | |
| ★★★★★(0) | JAIN VIVEK | - | 卖出 | 9,330 | - | - | 2026-05-19 | |
| ★★★★★(0) | ACURIO VERONICA | President, Orthodontics | 卖出 | 7,605 | - | - | 2026-02-25 | |
| ★★★★★(0) | KEEL PAUL A | Chief Executive Officer | 卖出 | 115,320 | - | - | 2026-02-25 | |
| ★★★★★(0) | HAMMES ERIC D. | Chief Financial Officer | 卖出 | 38,040 | - | - | 2026-02-25 | |
| ★★★★★(0) | NANCE MARK E | General Counsel | 卖出 | 23,070 | - | - | 2026-02-25 | |
| ★★★★★(0) | KEEL PAUL A | Chief Executive Officer | 卖出 | 11,840 | $29.59 | $350K | 2026-02-25 | |
| ★★★★★(0) | NILSSON STEFAN | President, Nobel Biocare | 卖出 | 7,605 | - | - | 2026-02-25 | |
| ★★★★★(0) | HAMMES ERIC D. | Chief Financial Officer | 卖出 | 2,045 | $29.59 | $61K | 2026-02-25 | |
| ★★★★★(0) | NILSSON STEFAN | President, Nobel Biocare | 卖出 | 182 | $29.59 | $5K | 2026-02-25 | |
| ★★★★★(0) | ACURIO VERONICA | President, Orthodontics | 卖出 | 13,845 | - | - | 2026-02-25 | |
| ★★★★★(0) | KAABI FAEZ C | Chief Accounting Officer | 卖出 | 13,520 | - | - | 2026-02-25 | |
| ★★★★★(0) | ACURIO VERONICA | President, Orthodontics | 卖出 | 18,020 | - | - | 2026-02-25 | |
| ★★★★★(0) | REIS MISCHA | SVP, Strategy & Bus. Dev. | 卖出 | 2,976 | $29.59 | $88K | 2026-02-25 | |
| ★★★★★(0) | BEFIDI ROBERT | President, Diagnostics | 卖出 | 18,020 | - | - | 2026-02-25 | |
| ★★★★★(0) | NANCE MARK E | General Counsel | 卖出 | 30,040 | - | - | 2026-02-25 | |
| ★★★★★(0) | REIS MISCHA | SVP, Strategy & Bus. Dev. | 卖出 | 5,915 | - | - | 2026-02-25 | |
| ★★★★★(0) | REIS MISCHA | SVP, Strategy & Bus. Dev. | 卖出 | 10,770 | - | - | 2026-02-25 | |
| ★★★★★(0) | KEEL PAUL A | Chief Executive Officer | 卖出 | 132,885 | - | - | 2026-02-25 | |
| ★★★★★(0) | HAMMES ERIC D. | Chief Financial Officer | 卖出 | 29,225 | - | - | 2026-02-25 | |
| ★★★★★(0) | KAABI FAEZ C | Chief Accounting Officer | 卖出 | 4,964 | $29.59 | $147K | 2026-02-25 | |
| ★★★★★(0) | HAMMES ERIC D. | Chief Financial Officer | 卖出 | 16,055 | - | - | 2026-02-25 | |
| ★★★★★(0) | REIS MISCHA | SVP, Strategy & Bus. Dev. | 卖出 | 14,020 | - | - | 2026-02-25 | |
| ★★★★★(0) | BEFIDI ROBERT | President, Diagnostics | 卖出 | 13,845 | - | - | 2026-02-25 | |
| ★★★★★(0) | KEEL PAUL A | Chief Executive Officer | 卖出 | 48,670 | - | - | 2026-02-25 | |
| ★★★★★(0) | NANCE MARK E | General Counsel | 卖出 | 12,675 | - | - | 2026-02-25 | |
| ★★★★★(0) | BEFIDI ROBERT | President, Diagnostics | 卖出 | 7,605 | - | - | 2026-02-25 | |
| ★★★★★(0) | NILSSON STEFAN | President, Nobel Biocare | 卖出 | 18,020 | - | - | 2026-02-25 | |
| ★★★★★(0) | ACURIO VERONICA | President, Orthodontics | 卖出 | 1,412 | $29.59 | $42K | 2026-02-25 | |
| ★★★★★(0) | NANCE MARK E | General Counsel | 卖出 | 3,368 | $29.59 | $100K | 2026-02-25 | |
| ★★★★★(0) | NILSSON STEFAN | President, Nobel Biocare | 卖出 | 13,845 | - | - | 2026-02-25 | |
| ★★★★★(0) | BEFIDI ROBERT | President, Diagnostics | 卖出 | 2,177 | $29.59 | $64K | 2026-02-25 | |
| ★★★★★(0) | REIS MISCHA | SVP, Strategy & Bus. Dev. | 卖出 | 5,634 | - | - | 2026-02-10 | |
| ★★★★★(0) | REIS MISCHA | SVP, Strategy & Bus. Dev. | 卖出 | 4,041 | - | - | 2026-02-10 | |
| ★★★★★(0) | KEEL PAUL A | Chief Executive Officer | 卖出 | 4,091 | $23.47 | $96K | 2026-02-01 | |
| ★★★★★(0) | BEFIDI ROBERT | President, Diagnostics | 卖出 | 998 | $23.47 | $23K | 2026-02-01 | |
| ★★★★★(0) | HAMMES ERIC D. | Chief Financial Officer | 卖出 | 1,119 | $23.47 | $26K | 2026-02-01 | |
| ★★★★★(0) | ACURIO VERONICA | President, Orthodontics | 卖出 | 998 | $23.47 | $23K | 2026-02-01 | |
| ★★★★★(0) | KAABI FAEZ C | Chief Accounting Officer | 卖出 | 1,186 | $23.47 | $28K | 2026-02-01 | |
| ★★★★★(0) | REIS MISCHA | SVP, Strategy & Bus. Dev. | 卖出 | 2,919 | $21.71 | $63K | 2026-02-01 | |
| ★★★★★(0) | NANCE MARK E | General Counsel | 卖出 | 2,006 | $23.47 | $47K | 2026-02-01 |